Royalty Pharma Plc (NASDAQ:RPRX) is one of the most profitable biotech stocks to buy. On October 10, Morgan Stanley analyst Terence Flynn slashed the price target on Royalty Pharma Plc (NASDAQ:RPRX) to $54 from$55 while keeping an overweight rating on the shares. Is Royalty Pharma plc (RPRX) The Most Profitable Biotech Stock To Buy Right Now? The rating update came ahead of Q3 earnings, with the firm telling investors in a preview for the biopharma group that it adjusted models for IQVIA trends along wi ...